DOI:
10.1055/s-00000071
Seminars in Neurology
LinksClose Window
References
Cramer SC, Fitzpatrick C, Warren M. et al.
The beta-hCG+ erythropoietin in acute stroke (BETAS) study: a 3-center, single-dose, open-label, noncontrolled, phase IIa safety trial.
Stroke 2010;
41 (05) 927-931
Access:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.